- Home
- RCUS vs NOG Comparison
RCUS vs NOG Comparison
Compare RCUS & NOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RCUS | NOG |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | 2018 | 2000 |
Fundamental Metrics
Financial Performance| Metric | RCUS | NOG |
|---|---|---|
| Price | $24.87 | $24.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 8 |
| Target Price | ★ $31.90 | $31.14 |
| AVG Volume (30 Days) | 1.3M | ★ 2.2M |
| Earning Date | 05-05-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 6.44% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $247,000,000.00 | ★ $2,475,723,000.00 |
| Revenue This Year | N/A | $14.07 |
| Revenue Next Year | $45.62 | $4.24 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 11.23 |
| 52 Week Low | $7.92 | $20.18 |
| 52 Week High | $28.72 | $32.62 |
Technical Indicators
Market Signals| Indicator | RCUS | NOG |
|---|---|---|
| Relative Strength Index (RSI) | 53.93 | 34.31 |
| Support Level | $23.91 | $23.51 |
| Resistance Level | $28.72 | $26.09 |
| Average True Range (ATR) | 1.81 | 0.82 |
| MACD | 0.00 | -0.18 |
| Stochastic Oscillator | 55.67 | 11.50 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About NOG Northern Oil and Gas Inc.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).